Vol. 64, No 141

Thursday,  July 23, 1999

Contents (TXT) (HTML)  (PDF)

RULES

NADA 141-151, CVM 9941.  Oral Dosage Form New Animal Drugs; Marbofloxacin Tablets.  [PRE-PUB] Pages 39918-39919 [FR Doc. 99-18769] [TXT] [PDF]

Freedom of Information Summary

NOTICES

Docket No. 98N-0320, OC 99187.  Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body.  [PRE-PUB] Page 40008 [FR Doc. 99-18770][TXT] [PDF]

Supporting Statement

Docket No. 98N-0222, OC 99173.  Agency Information Collection Activities; Submission for OMB Review; Comment Request; Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices.  [PRE-PUB] Pages 40008-40012 [FR Doc. 99-18767][TXT] [PDF]

OC 99161.  Clinical Studies of Safety and Effectiveness of Orphan Products; Availability of Grants; Request for Applications.  [PRE-PUB]  Pages 40012-40016 [FR Doc. 99-18771] [TXT] [PDF]

MEETINGS

OC 99191.  General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee. Notice of Meeting on August 2. 1999.  [PRE-PUB]  Pages 40016-40017 [FR Doc. 99-18768][TXT] [PDF]